122 related articles for article (PubMed ID: 17673329)
1. Lung cancer after exposure to disease modifying anti-rheumatic drugs.
Bernatsky S; Clarke A; Suissa S
Lung Cancer; 2008 Feb; 59(2):266-9. PubMed ID: 17673329
[TBL] [Abstract][Full Text] [Related]
2. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
[TBL] [Abstract][Full Text] [Related]
3. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
Bernatsky S; Hudson M; Suissa S
Rheumatology (Oxford); 2005 May; 44(5):677-80. PubMed ID: 15784627
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.
Brassard P; Lowe AM; Bernatsky S; Kezouh A; Suissa S
Arthritis Rheum; 2009 Mar; 61(3):300-4. PubMed ID: 19248128
[TBL] [Abstract][Full Text] [Related]
5. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis.
Bernatsky S; Clarke AE; Suissa S
Arch Intern Med; 2008 Feb; 168(4):378-81. PubMed ID: 18299492
[TBL] [Abstract][Full Text] [Related]
6. Antirheumatic drug use and the risk of acute myocardial infarction.
Suissa S; Bernatsky S; Hudson M
Arthritis Rheum; 2006 Aug; 55(4):531-6. PubMed ID: 16874796
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.
Setoguchi S; Solomon DH; Weinblatt ME; Katz JN; Avorn J; Glynn RJ; Cook EF; Carney G; Schneeweiss S
Arthritis Rheum; 2006 Sep; 54(9):2757-64. PubMed ID: 16947774
[TBL] [Abstract][Full Text] [Related]
8. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.
Bernatsky S; Hudson M; Suissa S
Rheumatology (Oxford); 2007 Jul; 46(7):1157-60. PubMed ID: 17478469
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
10. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans.
Khurana R; Wolf R; Berney S; Caldito G; Hayat S; Berney SM
J Rheumatol; 2008 Sep; 35(9):1704-8. PubMed ID: 18634160
[TBL] [Abstract][Full Text] [Related]
11. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.
Schmajuk G; Schneeweiss S; Katz JN; Weinblatt ME; Setoguchi S; Avorn J; Levin R; Solomon DH
Arthritis Rheum; 2007 Aug; 57(6):928-34. PubMed ID: 17665462
[TBL] [Abstract][Full Text] [Related]
12. Antirheumatic drugs and the risk of tuberculosis.
Brassard P; Kezouh A; Suissa S
Clin Infect Dis; 2006 Sep; 43(6):717-22. PubMed ID: 16912945
[TBL] [Abstract][Full Text] [Related]
13. The risk of hospitalized infection in patients with rheumatoid arthritis.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
J Rheumatol; 2008 Mar; 35(3):387-93. PubMed ID: 18260176
[TBL] [Abstract][Full Text] [Related]
14. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
[TBL] [Abstract][Full Text] [Related]
15. Predictors of infection in rheumatoid arthritis.
Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Sep; 46(9):2294-300. PubMed ID: 12355476
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
Suissa S; Hudson M; Ernst P
Arthritis Rheum; 2006 May; 54(5):1435-9. PubMed ID: 16645972
[TBL] [Abstract][Full Text] [Related]
17. Gaps in care for rheumatoid arthritis: a population study.
Lacaille D; Anis AH; Guh DP; Esdaile JM
Arthritis Rheum; 2005 Apr; 53(2):241-8. PubMed ID: 15818655
[TBL] [Abstract][Full Text] [Related]
18. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Agarwal S; Zaman T; Handa R
Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
[TBL] [Abstract][Full Text] [Related]
19. Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis.
Grijalva CG; Chung CP; Arbogast PG; Stein CM; Mitchel EF; Griffin MR
Med Care; 2007 Oct; 45(10 Supl 2):S66-76. PubMed ID: 17909386
[TBL] [Abstract][Full Text] [Related]
20. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
Crowson CS; Nicola PJ; Kremers HM; O'Fallon WM; Therneau TM; Jacobsen SJ; Roger VL; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Oct; 52(10):3039-44. PubMed ID: 16200583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
